These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 22064592)
1. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Pinto DS; Frederick PD; Chakrabarti AK; Kirtane AJ; Ullman E; Dejam A; Miller DP; Henry TD; Gibson CM; Circulation; 2011 Dec; 124(23):2512-21. PubMed ID: 22064592 [TBL] [Abstract][Full Text] [Related]
2. Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy. Chakrabarti AK; Gibson CM; Pinto DS Curr Opin Cardiol; 2012 Nov; 27(6):651-4. PubMed ID: 23032713 [TBL] [Abstract][Full Text] [Related]
3. Outcome in patients transferred for percutaneous coronary intervention (a national registry of myocardial infarction 2/3/4 analysis). Shavelle DM; Rasouli ML; Frederick P; Gibson CM; French WJ; Am J Cardiol; 2005 Nov; 96(9):1227-32. PubMed ID: 16253587 [TBL] [Abstract][Full Text] [Related]
4. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Nallamothu BK; Bates ER; Herrin J; Wang Y; Bradley EH; Krumholz HM; Circulation; 2005 Feb; 111(6):761-7. PubMed ID: 15699253 [TBL] [Abstract][Full Text] [Related]
5. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry. McCabe JM; Armstrong EJ; Hoffmayer KS; Bhave PD; MacGregor JS; Hsue P; Stein JC; Kinlay S; Ganz P Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):672-9. PubMed ID: 22949494 [TBL] [Abstract][Full Text] [Related]
6. Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction. Miedema MD; Newell MC; Duval S; Garberich RF; Handran CB; Larson DM; Mulder S; Wang YL; Lips DL; Henry TD Circulation; 2011 Oct; 124(15):1636-44. PubMed ID: 21931079 [TBL] [Abstract][Full Text] [Related]
7. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Pinto DS; Kirtane AJ; Nallamothu BK; Murphy SA; Cohen DJ; Laham RJ; Cutlip DE; Bates ER; Frederick PD; Miller DP; Carrozza JP; Antman EM; Cannon CP; Gibson CM Circulation; 2006 Nov; 114(19):2019-25. PubMed ID: 17075010 [TBL] [Abstract][Full Text] [Related]
8. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Gibson CM; Pride YB; Frederick PD; Pollack CV; Canto JG; Tiefenbrunn AJ; Weaver WD; Lambrew CT; French WJ; Peterson ED; Rogers WJ Am Heart J; 2008 Dec; 156(6):1035-44. PubMed ID: 19032997 [TBL] [Abstract][Full Text] [Related]
9. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. Le May MR; So DY; Dionne R; Glover CA; Froeschl MP; Wells GA; Davies RF; Sherrard HL; Maloney J; Marquis JF; O'Brien ER; Trickett J; Poirier P; Ryan SC; Ha A; Joseph PG; Labinaz M N Engl J Med; 2008 Jan; 358(3):231-40. PubMed ID: 18199862 [TBL] [Abstract][Full Text] [Related]
10. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. McNamara RL; Wang Y; Herrin J; Curtis JP; Bradley EH; Magid DJ; Peterson ED; Blaney M; Frederick PD; Krumholz HM; J Am Coll Cardiol; 2006 Jun; 47(11):2180-6. PubMed ID: 16750682 [TBL] [Abstract][Full Text] [Related]
11. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T; Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434 [TBL] [Abstract][Full Text] [Related]
12. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Ting HH; Rihal CS; Gersh BJ; Haro LH; Bjerke CM; Lennon RJ; Lim CC; Bresnahan JF; Jaffe AS; Holmes DR; Bell MR Circulation; 2007 Aug; 116(7):729-36. PubMed ID: 17673456 [TBL] [Abstract][Full Text] [Related]
13. Clinical impact of an inter-hospital transfer strategy in patients with ST-elevation myocardial infarction undergoing primary angioplasty: the Emilia-Romagna ST-segment elevation acute myocardial infarction network. Manari A; Ortolani P; Guastaroba P; Casella G; Vignali L; Varani E; Piovaccari G; Guiducci V; Percoco G; Tondi S; Passerini F; Santarelli A; Marzocchi A Eur Heart J; 2008 Aug; 29(15):1834-42. PubMed ID: 18617475 [TBL] [Abstract][Full Text] [Related]
14. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Hudson MP; Armstrong PW; O'Neil WW; Stebbins AL; Weaver WD; Widimsky P; Aylward PE; Ruzyllo W; Holmes D; Mahaffey KW; Granger CB Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):183-92. PubMed ID: 21304097 [TBL] [Abstract][Full Text] [Related]
15. Reduction of delays in primary percutaneous coronary intervention. Daneault B; Do DH; Maltais A; Bérubé S; Harvey R; Gervais A; Dalery K; Nguyen M Can J Cardiol; 2011; 27(5):562-6. PubMed ID: 21641175 [TBL] [Abstract][Full Text] [Related]
16. Nationwide improvement of door-to-balloon times in patients with acute ST-segment elevation myocardial infarction requiring primary percutaneous coronary intervention with out-of-hospital 12-lead ECG recording and transmission. Ong ME; Wong AS; Seet CM; Teo SG; Lim BL; Ong PJ; Lai SM; Ong SH; Lee FC; Chan KP; Anantharaman V; Chua TS; Pek PP; Li H Ann Emerg Med; 2013 Mar; 61(3):339-47. PubMed ID: 23021348 [TBL] [Abstract][Full Text] [Related]
17. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options. Boden WE; Eagle K; Granger CB J Am Coll Cardiol; 2007 Sep; 50(10):917-29. PubMed ID: 17765117 [TBL] [Abstract][Full Text] [Related]
18. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E; Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504 [TBL] [Abstract][Full Text] [Related]
19. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte. Zahn R; Vogt A; Zeymer U; Gitt AK; Seidl K; Gottwik M; Weber MA; Niederer W; Mödl B; Engel HJ; Tebbe U; Senges J; Heart; 2005 Aug; 91(8):1041-6. PubMed ID: 16020592 [TBL] [Abstract][Full Text] [Related]
20. Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for st-segment elevation myocardial infarction. Hannan EL; Zhong Y; Jacobs AK; Holmes DR; Walford G; Venditti FJ; Stamato NJ; Sharma S; King SB Am J Cardiol; 2010 Jul; 106(2):143-7. PubMed ID: 20598994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]